Ysios Capital has supplied a series A extension that follows an initial tranche co-led by Kurma Partners and Sunstone Life Science Ventures in November 2020.

Tiger Global Management led a series F round for Samsung and Qualcomm-backed cybersecurity software provider SentinelOne at a valuation topping $3bn.

Based on Aalto University and VTT research, IQM Quantum Computers has lured investors including Tencent to bring its equity and grant funding total to $83.9m.

Julius-Maximilians-University of Würzburg's cancer immunotherapy developer Catalym plans to move its lead asset into the clinic next month.

Legend Capital was among the participants as Rec-Biotechnology raised series B funding that will be used for clinical trials of its vaccine candidates.

The digital mortgage lender increased its valuation from $600m to $4bn in a series D round backed by Ping An and American Express Ventures.

Salesforce Ventures returned to help the virtual event software provider hike its valuation to $2.15bn in its third round this year.

The genitourinary tumour drug developer's latest round follows a June series C-plus round featuring C&D, Tigermed and SAIC Capital.

3M Ventures and NTTVC joined new and existing investors to help the cardiopulmonary virtual care provider boost its overall funding to $92m.

Novartis Venture Fund took part in a series B round closed as Catalym prepares to move its lead cancer immunotherapy asset into the clinic next month.